NL-OMON49967撤回2 期
COVID-19: ultra-Low Radiotherapy Dose1: Colorado-1 trial - COLORADO-1
niversitair Medisch Centrum Utrecht0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •* PCR confirmed positive for SARS-CoV-2
- •* Progressive respiratory insufficiency with the following:
- •o National Early Warning Score (NEWS) * 5.
- •o Respiratory rate * 20/min
- •o Supplemental oxygen * 6L/min
- •* DNR (Do not resuscitate, *NRNB*).
- •* Clinical frailty scale 5-8 at admission.
- •* Age * 50 years.
- •* Ability of subject to understand character and individual consequences of the
- •clinical trial.
排除标准
- •* Medical indication to be treated at the ICU (intensive care unit).
- •* Current participation in other intervention studies.
- •* Prior thoracic radiotherapy only if * grade 3 toxicity has been registered.
- •* Inability to undergo radiotherapy or transportation, for any reason as
- •determined by the treating physician.
- •* Alternative diagnosis for respirator insufficiency which is considered to be
- •more likely than COVID-19.
- •* Current treatment with immunomodulating therapy other than steroids.
研究者
相似试验
尚未招募
2 期
ow Dose Radiotherapy for COVID-19 Pneumonia using a Linear acceleratorCTRI/2021/06/033911Guru Hospitals
Unknown
不适用
Low-Dose Radiation Therapy to Lungs in Moderate COVID-19 Pneumonitis: A Case-Control Pilot StudyCOVID-19PneumoniaNCT04904783Mahatma Gandhi Institute of Medical Sciences20
尚未招募
2 期
Low-Dose Radiation Therapy for Severe COVID-19 PneumoniaCOVID-19 PneumoniaNCT05694962Jiangsu Cancer Institute & Hospital40
招募中
1 期
Reduced intensity radio-chemotherapy for stage IIA/B seminomaStage IIA/B seminomaMedDRA version: 21.0Level: PTClassification code: 10043351Term: Testicular seminoma (pure) stage II Class: 100000004864CTIS2023-509663-24-00Swiss Group for Clinical Cancer Research180
招募中
1 期
ow Dose Radiation Therapy for COVID-19CTRI/2020/06/025862ot yet applied for funding